Recent News

• 03.17.2026 - 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.17.2026 - Abeona Therapeutics® Reports Full Year 2025 Financial Results and Corporate Updates
• 03.09.2026 - Abeona Therapeutics® Provides Business Update Highlighting Building Momentum in ZEVASKYN® Commercial Launch
• 03.03.2026 - Abeona Therapeutics® Announces Date of Fourth Quarter / Full Year 2025 Financial Results and Participation in Upcoming 2026 Leerink Global Healthcare Conference
• 02.09.2026 - Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 02.09.2026 - Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Recent Filings

• 03.09.2026 - 8-K Current report
• 03.09.2026 - EX-99.1 EX-99.1
• 02.12.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.09.2026 - 144 Report of proposed sale of securities
• 02.04.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.02.2026 - 144 Report of proposed sale of securities
• 02.02.2026 - 144 Report of proposed sale of securities
• 02.02.2026 - 144 Report of proposed sale of securities